PT89916A - Processo para a producao de proteinas modificadas - Google Patents
Processo para a producao de proteinas modificadasInfo
- Publication number
- PT89916A PT89916A PT89916A PT8991689A PT89916A PT 89916 A PT89916 A PT 89916A PT 89916 A PT89916 A PT 89916A PT 8991689 A PT8991689 A PT 8991689A PT 89916 A PT89916 A PT 89916A
- Authority
- PT
- Portugal
- Prior art keywords
- amino acids
- production
- modified proteins
- mutants
- leu
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Insects & Arthropods (AREA)
- Pest Control & Pesticides (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH84088 | 1988-03-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT89916A true PT89916A (pt) | 1989-11-10 |
PT89916B PT89916B (pt) | 1994-05-31 |
Family
ID=4196431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT89916A PT89916B (pt) | 1988-03-07 | 1989-03-06 | Processo para a producao de proteinas modificadas |
Country Status (20)
Country | Link |
---|---|
US (1) | US5079229A (pt) |
EP (1) | EP0332576B1 (pt) |
JP (1) | JP2716191B2 (pt) |
KR (1) | KR0134377B1 (pt) |
AT (1) | ATE103930T1 (pt) |
AU (1) | AU623881B2 (pt) |
CA (1) | CA1339105C (pt) |
DD (1) | DD283645A5 (pt) |
DE (1) | DE58907373D1 (pt) |
DK (1) | DK107389A (pt) |
ES (1) | ES2063161T3 (pt) |
FI (1) | FI96116C (pt) |
HU (1) | HU209401B (pt) |
IE (1) | IE62993B1 (pt) |
IL (1) | IL89496A0 (pt) |
NO (1) | NO178870C (pt) |
NZ (1) | NZ228208A (pt) |
PT (1) | PT89916B (pt) |
TW (1) | TW211522B (pt) |
ZA (1) | ZA891679B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6342373B1 (en) * | 1983-11-21 | 2002-01-29 | Ucp Gen-Pharma Ag | Process for preparing recombinant eglin, protease inhibitor |
US5674833A (en) * | 1990-09-18 | 1997-10-07 | Novo Nordisk A/S | Detergent compositions containing protease and novel inhibitors for use therein |
US5604201A (en) * | 1993-01-08 | 1997-02-18 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Methods and reagents for inhibiting furin endoprotease |
TW492975B (en) * | 1993-07-26 | 2002-07-01 | Novartis Ag | Tryptase inhibitor |
DE69722639T2 (de) | 1996-09-24 | 2004-04-29 | The Procter & Gamble Company, Cincinnati | Stabilisierte proteine mit protease-inhibitorfunktion und varianten davon |
US7001884B2 (en) * | 2001-06-18 | 2006-02-21 | Regents Of The University Of Michigan | Eglin c based drugs for treatment of disease |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2125047B (en) * | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
DE3324534A1 (de) * | 1983-07-07 | 1985-01-17 | Ciba-Geigy Ag, Basel | Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel |
CA1297437C (en) * | 1983-11-21 | 1992-03-17 | Hans Rink | Process for the preparation of protease inhibitors |
US4711848A (en) * | 1984-03-14 | 1987-12-08 | Zymogenetics, Inc. | Site specific mutagenesis in alpha-1-antitrypsin |
EP0164719B1 (en) * | 1984-06-14 | 1992-05-06 | Chiron Corporation | Active site modified protease alpha-1-antitrypsin inhibitors and their production |
DE3587875T3 (de) * | 1984-12-06 | 2003-01-02 | Amgen Inc.(N.D.Ges D. Staates Delaware), Thousand Oaks | Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu. |
GB2188322A (en) * | 1986-03-26 | 1987-09-30 | Bayer Ag | Aprotinin and analogues thereof produced by a recombinant host |
GB2199582A (en) * | 1987-01-07 | 1988-07-13 | Bayer Ag | Analogues of pancreatic secretory trypsin inhibitor |
-
1989
- 1989-02-28 AT AT89810152T patent/ATE103930T1/de not_active IP Right Cessation
- 1989-02-28 EP EP89810152A patent/EP0332576B1/de not_active Expired - Lifetime
- 1989-02-28 ES ES89810152T patent/ES2063161T3/es not_active Expired - Lifetime
- 1989-02-28 DE DE89810152T patent/DE58907373D1/de not_active Expired - Fee Related
- 1989-03-03 AU AU30959/89A patent/AU623881B2/en not_active Ceased
- 1989-03-03 NZ NZ228208A patent/NZ228208A/xx unknown
- 1989-03-03 FI FI891020A patent/FI96116C/fi not_active IP Right Cessation
- 1989-03-03 CA CA000592686A patent/CA1339105C/en not_active Expired - Fee Related
- 1989-03-06 NO NO890932A patent/NO178870C/no not_active IP Right Cessation
- 1989-03-06 IL IL89496A patent/IL89496A0/xx not_active IP Right Cessation
- 1989-03-06 PT PT89916A patent/PT89916B/pt not_active IP Right Cessation
- 1989-03-06 HU HU891101A patent/HU209401B/hu not_active IP Right Cessation
- 1989-03-06 DD DD89326310A patent/DD283645A5/de not_active IP Right Cessation
- 1989-03-06 DK DK107389A patent/DK107389A/da not_active Application Discontinuation
- 1989-03-06 IE IE71989A patent/IE62993B1/en not_active IP Right Cessation
- 1989-03-06 ZA ZA891679A patent/ZA891679B/xx unknown
- 1989-03-07 TW TW078101663A patent/TW211522B/zh active
- 1989-03-07 KR KR1019890002759A patent/KR0134377B1/ko not_active IP Right Cessation
- 1989-03-07 JP JP1053065A patent/JP2716191B2/ja not_active Expired - Lifetime
- 1989-03-07 US US07/320,139 patent/US5079229A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI96116B (fi) | 1996-01-31 |
EP0332576B1 (de) | 1994-04-06 |
KR0134377B1 (ko) | 1998-04-20 |
NO890932L (no) | 1989-09-08 |
ES2063161T3 (es) | 1995-01-01 |
FI891020A0 (fi) | 1989-03-03 |
JP2716191B2 (ja) | 1998-02-18 |
AU623881B2 (en) | 1992-05-28 |
EP0332576A2 (de) | 1989-09-13 |
DE58907373D1 (de) | 1994-05-11 |
EP0332576A3 (en) | 1990-09-12 |
CA1339105C (en) | 1997-07-29 |
FI891020A (fi) | 1989-09-08 |
NO178870C (no) | 1996-06-19 |
TW211522B (pt) | 1993-08-21 |
PT89916B (pt) | 1994-05-31 |
NO178870B (no) | 1996-03-11 |
IL89496A0 (en) | 1989-09-10 |
HUT50503A (en) | 1990-02-28 |
IE62993B1 (en) | 1995-03-08 |
FI96116C (fi) | 1996-05-10 |
ATE103930T1 (de) | 1994-04-15 |
US5079229A (en) | 1992-01-07 |
AU3095989A (en) | 1989-09-07 |
ZA891679B (en) | 1989-10-25 |
DK107389D0 (da) | 1989-03-06 |
DK107389A (da) | 1989-09-08 |
DD283645A5 (de) | 1990-10-17 |
IE890719L (en) | 1989-09-07 |
KR890014735A (ko) | 1989-10-25 |
JPH029392A (ja) | 1990-01-12 |
NZ228208A (en) | 1990-08-28 |
NO890932D0 (no) | 1989-03-06 |
HU209401B (en) | 1994-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2124685T3 (es) | Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso. | |
DE59006837D1 (de) | Verfahren zur fermentativen Herstellung von Aminosäuren, insbesondere L-Lysin, dafür geeignete Mikroorganismen und rekombinante DNA. | |
BR9407820A (pt) | Processo para produçao de um concentrado de proteina enriquecido com aglucono isoflavonas a partir de um material de proteina vegetal concentrado de proteina enriquecido com aglucono isoflavona concentrado de proteina enriquecido com aglucono isoflavona e processo para recuperação em um concentrado de proteina pelo menos 50% de uma isoflavona em um material de proteina vegetal | |
BR8301918A (pt) | Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase | |
ES2065911T3 (es) | Produccion de proteinas en formas activas. | |
DE68918867D1 (de) | Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen. | |
ATE449850T1 (de) | Mutanten von flt3-l und ihre verwendungen | |
NO885013D0 (no) | Fremgangsmte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppndd ved fremgangsmten. | |
PT89916A (pt) | Processo para a producao de proteinas modificadas | |
HU895788D0 (en) | Process for producing peptides and medical products containing them | |
PT98669A (pt) | Processo para a preparacao da estrutura proteica da toxina de gelonina vegetal | |
ES2168282T3 (es) | D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion. | |
PT90739A (pt) | Processo para a preparacao de uma proteina dotada de actividade de inibicao de trombina | |
BR9003385A (pt) | Processo para a producao de proteinas vegetais hidrolisadas,produto e proteina vegetal hidrolisada | |
ES2170144T3 (es) | Variantes que no se empalman de gp350/220. | |
KR890008166A (ko) | 융합 단백질의 선택적 분해 방법 | |
DE69012989D1 (de) | Peptiden von retinblastoma gen produkten und antikoerper dagegen. | |
DE59106997D1 (de) | Ancrod ähnliche proteine, ihre herstellung und verwendung. | |
EP0288057A3 (en) | Des-19-leucine, 20-glutamine, 21-threonine, 22-tyrosine-calcitonin | |
HUT37109A (en) | Process for the phosphinoylation of amino gropus of amino-acids, peptides and esters thereof | |
IT8223609A0 (it) | Procedimento per l'estrazione di sostanze azotate, in particolare proteine e/o amminoacidi da sostanze vegetali, in particolare da sottoprodotti della lavorazione della soia. | |
ATE92102T1 (de) | Genfragmente, die die variable region eines anti- hiv-antikoerpers codieren, von diesen exprimierte chimaere anti-hiv-antikoerper und verfahren zu deren herstellung. | |
NO941982L (no) | Fremstilling av proteiner ved anvendelse av 7B2 protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19931118 |
|
PC3A | Transfer or assignment |
Free format text: 970410 NOVARTIS AG CH |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20030531 |